
|Videos|February 14, 2022
Why saw palmetto should not be overlooked in treatment of LUTS
Author(s)Urology Times staff
“I think it's important for urologists and physicians to have an open mind in regard to complementary approaches to the treatment of BPH-related LUTS in men,” says J. Curtis Nickel, MD, FRCSC.
Advertisement
In this video, J. Curtis Nickel, MD, FRCSC, discusses future research on saw palmetto and why he thinks there is enough evidence to support urologists prescribing this medication to patients suffering from lower urinary tract symptoms secondary to benign prostatic hyperplasia. Nickel is a professor of urology at Queen’s University, and a research chair in urologic pain and inflammation at Kingston Health Sciences Centre, Kingston, Ontario, Canada.
Advertisement
Latest CME
Advertisement
Advertisement
Trending on Urology Times
1
FDA approves lutetium Lu 177 vipivotide tetraxetan for PSMA-positive mHSPC
2
Testosterone deficiency: FAQs from the AUA guideline
3
Joshua Lang, MD, MS, on integrating molecular biomarkers into clinical practice
4
Large registry study reports durable 10-year outcomes with focal therapy for prostate cancer
5












